5/21/2018 .pdf

1/101

,

,RN,MA

-135-145 meq/l - - -":ADH, Renin-Angiotensin-

Aldosteron system

>135meq/l :

-

,-

:),(' 1.2.:'3. - - -SIADH

)

):>48

5/21/2018 .pdf

2/102

,3. ,4.,5. 6. 7.

:

!!! !!!

: PO,PZ,IV1. -

IV NaCl 0.9%, Ringers Lactated sol

.2 12 meq/l-( )Demyelination

:IV NaCl 3.

)"800(4..5SIADH:, +fusid.6AVP antagonist- IV Conivaptane

(Vaprisol)

-

( )

5/21/2018 .pdf

3/103

:.1 2.

: 1..2

:1. (

) 2.3. 4..5Diabetes Insipidus

.6 , (IVNaBicarbonat(

:1. 2.: 3.--- - -

:Na > 145 meq/l

Osm (bl) > 300 mosm/lOsm (ur)

: !!!

)(1.

(IV Glu 5%)

2.

3. 0.5-1 meq/h

.4Desmopressin (Minirin)Diabetes Insipidus

5/21/2018 .pdf

4/104

:1.2. 3. 4.5.

DI - SIADH

Na/Osm (Ur)

Na/Osm (Bl)

DISIADH

- :3.5-5.0 meq/l- -- -

) )-"-RAAS

>3.5 meq/l:1..2 :,,,('- )-((Cushing dis - -

:,1. ,2. 3.4.

TU

5/21/2018 .pdf

5/105

:1.2. PO/IV.3 ) , , (-

:+1.2.3.

:IV1. IM ,2.

.3 : 20 meq/100 cc/h: 4. ,20 meq/100 cc 5.

5/21/2018 .pdf

6/106

)(1. Kayexalate2.

:1. )(2. .3IV Calcium gluconate.4IV NaBicarbonate.5IV Reg Insulin + glucose.6IV Fusid.7Inh Ventoline.8Kayxalate9.

:1. 2. 3. 4.

99 %1 % - '

( ) 8.6-10.2 mg/dl -++ Ca

1.1-1.3 mmol/l

.1PTH hormone.2Calcitonin

: 1. 2. ) ( 3.4.D 5.

5/21/2018 .pdf

7/107

:1. , 2..3Trousseaus , Chvosteks signs

4.

,, 5.

6.

,7.

8.

) :().(IV Calcium1. 2.

_____________________________

: .1Vit. D

2.

3.

4.

:1.)( 2. 3. Calcium 4.

50%

: 1. 2. 3.

:1. - ) ( 2., ,3. 4.: 5.-6.

:1. ) +(NaCl 0.9%2. 3. .4IM Calcitonin

5.

.6Mithrhtramycin

7.

8.

5/21/2018 .pdf

8/108

:1. 2. 3.4. 5.

-- :1.51.51.51.5----2.5 meq/L2.5 meq/L2.5 meq/L2.5 meq/L

>1.5

:'

: ),

) , ,

:

IVIVIVIV ( )

2.5

:- )OTCOTCOTCOTC (MaaloxMaaloxMaaloxMaalox

:

' -

5/21/2018 .pdf

9/109

:

IV CalciumIV CalciumIV CalciumIV Calcium

:2.52.52.52.5----4.5 mg/4.5 mg/4.5 mg/4.5 mg/dLdLdLdL

ATPATPATPATP - ) ) -

:

-

: ) IVIVIVIV)IVIVIVIVPOPOPOPO

:

- : ,:,:

,,CSF :96-106meq/L

:, ' :, ,:

5/21/2018 .pdf

10/1010

: :, ,

: ,- , , , -